Stockscreener 앱 받기
0.208
4.59%
-0.01
전일 마감가:
$0.218
열려 있는:
$0.22
하루 거래량:
1.00M
Relative Volume:
1.19
시가총액:
$4.00M
수익:
$5.54M
순이익/손실:
$-4.74M
주가수익비율:
-0.619
EPS:
-0.336
순현금흐름:
$-750.60K
1주 성능:
-3.70%
1개월 성능:
-3.70%
6개월 성능:
+2.87%
1년 성능:
-58.40%
1일 변동 폭
$0.18
$0.2202
1주일 범위
$0.18
$0.24
52주 변동 폭
$0.13
$0.49
China Pharma Holdings Inc. Stock (CPHI) Company Profile
명칭
China Pharma Holdings Inc.
전화
86 898 6681 1730
주소
No. 17, Jinpan Road, Second Floor, Haikou
CPHI을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CPHI
China Pharma Holdings Inc.
|
0.208 | 4.00M | 5.54M | -4.74M | -750.60K | -0.336 |
|
ZTS
Zoetis Inc
|
160.46 | 71.85B | 9.26B | 2.49B | 2.30B | 5.47 |
|
HLN
Haleon Plc Adr
|
10.08 | 45.58B | 14.26B | 1.55B | 0 | 0.3383 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.06 | 44.58B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.74 | 19.18B | 16.54B | -1.64B | 749.00M | -1.45 |
|
ITCI
Intra Cellular Therapies Inc
|
128.60 | 13.67B | 612.78M | -86.37M | -62.91M | -0.87 |
China Pharma Holdings Inc. Stock (CPHI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2010-01-08 | 개시 | Rodman & Renshaw | Mkt Outperform |
China Pharma Holdings Inc. 주식(CPHI)의 최신 뉴스
Hong Kong Pharma Digital Technology Holdings Limited Partners with Leading Chinese E-commerce Platform to Enhance Cross-Border Logistics Services - PR Newswire
VIBATIV® RECEIVES MARKETING APPROVAL IN CHINA - PR Newswire
InnoCare Pharma receives approval for CLL/SLL combination therapy trial in China - Yahoo
China Pharma (NYSE:CPHI) Coverage Initiated by Analysts at StockNews.com - Defense World
Is Pfizer Inc. (PFE) the Best Drug Stock to Buy Now? - Yahoo Finance
Why AbbVie Inc. (ABBV) Is One of the Best Drug Stocks to Buy Now - Yahoo Finance
U.S. investors, Big Pharma race to find new medicines in China - MSN
Corbus Pharmaceuticals Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits - Quantisnow
CRB-701 (SYS6002) A Next Generation Nectin-4 Targeting ADC Demonstrates Encouraging Safety and Broader Efficacy in Phase 1 Study in the US and UK Presented at ASCO-GU 2025 - Quantisnow
China Pharma (NYSE:CPHI) Now Covered by StockNews.com - Defense World
Hong Kong Stock Exchange Companies List - Morningstar.com.au
Layoff Tracker: Viracta, X4 and BMS Detail Current, Upcoming Cuts - BioSpace
China Pharma Holdings Inc (CPHI) Stock: A Year of Stock Market Dynamics - The InvestChronicle
Post-Trade Analysis: China Pharma Holdings Inc (CPHI) Slides -7.63, Closing at 0.21 - The Dwinnex
Closing Bell Recap: International Paper Co (IP) Ends at 53.89, Reflecting a -3.47 Downturn - The Dwinnex
Big Pharma is staying quiet on Trump's China tariffs - Yahoo Finance
China Medical System Holdings Limited (HKG:867) insiders have significant skin in the game with 52% ownership - Simply Wall St
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Shares Bought by China Universal Asset Management Co. Ltd. - MarketBeat
China Universal Asset Management Co. Ltd. Acquires 8,018 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Acquired by China Universal Asset Management Co. Ltd. - MarketBeat
China Pharma (NYSE:CPHI) Now Covered by Analysts at StockNews.com - Defense World
Pharmaceuticals Wholesale and Distribution Market to grow by USD 896.5 Billion (2024-2028), driven by rising global pharmaceutical sales, Report on how AI is redefining market landscapeTechnavio - Yahoo Finance
China NT Pharma Group to Hold Extraordinary General Meeting for New Share Subscription Approval - TipRanks
China Pharma (NYSE:CPHI) Earns Hold Rating from Analysts at StockNews.com - Defense World
Ascentage Pharma Prices U.S. IPO At $17.25/ADS - RTTNews
Asia Hedge Funds Post Biggest Annual Returns Since the Pandemic - Bloomberg
Henlius Biotech shareholders reject take-private offer from China's Fosun - Reuters.com
Tariff threats, drug pricing will be 2 key pharma issues during Trump's first year - Yahoo Finance
‘The bar has risen’: China’s biotech gains push US companies to adapt - BioPharma Dive
Ascentage Pharma Group International (OTCMKTS:ASPHF) Short Interest Update - Defense World
The top 10 biopharma M&A deals of 2024 - FiercePharma
Dry Eye Products Market Opportunities and Strategies to - GlobeNewswire
Li Ka-Shing-Backed Hutchmed Sells Stake in Unit for $608 Million - MSN
Barclays PLC Has $759,000 Holdings in UroGen Pharma Ltd. (NASDAQ:URGN) - Defense World
StockNews.com Begins Coverage on China Pharma (NYSE:CPHI) - Defense World
China Pharma Holdings, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2019 - Marketscreener.com
China Pharma Holdings, Inc. Rescinds Securities Purchase Agreement - Defense World
PetVivo Holdings, Inc. to Make Investor Presentations - Defense World
Keen Vision Acquisition Extends Business Combination PeriodKeen Vision Acquisition Corporation (NASDAQ: KVAC) has recently filed a Form 8-K with the Securities and Exchange Commission, announcing the extension of its business combination period. T - Defense World
AmpliTech Group Enters Securities Purchase Agreement with Institutional InvestorsWASHINGTON, D.C., December 24, 2024 – AmpliTech Group, Inc. (NASDAQ: AMPG) disclosed today in an 8-K filing with the Securities and Exchange Commission that it has - Defense World
Blackboxstocks Inc. Dismisses Turner, Stone & Company as Independent Registered Public Accounting Firm; Engages Victor Mokuolo CPA PLLC as ReplacementOn December 20, 2024, Blackboxstocks Inc. (NASDAQ: BLBX) made significant changes in its a - Defense World
The Glimpse Group Announces Closing of $7.29 Million OfferingWASHINGTON, D.C., December 23, 2024 – The Glimpse Group, Inc. (NASDAQ:VRAR) disclosed the finalization of a registered direct offering on December 23, 2024. The undertaking involved a - Defense World
Creative Medical Technology Holdings, Inc. Reports Amendment to Articles of Incorporation and Voting Results Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) filed a Form 8-K with the Securities and Exchange Commission on December 19, 20 - Defense World
Analysts Set Celsius Holdings, Inc. (NASDAQ:CELH) Price Target at $50.28 - Defense World
China Pharma Holdings, Inc. Successfully Conducts Annual Stockholders’ Meeting - Defense World
GlycoMimetics Receives Extension Notice from Nasdaq Regarding Minimum Bid Price ComplianceOn December 19, 2024, GlycoMimetics, Inc. (NASDAQ: GLYC) disclosed in an 8-K filing with the Securities and Exchange Commission that it had received an e - Defense World
**Rhinebeck Bancorp Completes Balance Sheet Repositioning, Projects Earnings Growth** - Defense World
Wrap Technologies Reports Approval of Incentive Plan Amendment and Director Elections at Annual Meeting - Defense World
Financial Review: Autozi Internet Technology (Global) (NASDAQ:AZI) vs. Driven Brands (NASDAQ:DRVN) - Defense World
Aker BP ASA (OTCMKTS:AKRBF) Trading Down 1.7% – Here’s What Happened - Defense World
Edesa Biotech, Inc. (NASDAQ:EDSA) Short Interest Update - Defense World
China Pharma Holdings Inc. (CPHI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.23%
3.94%
자본화:
|
볼륨(24시간):